Specific situations requiring medical review include: Severe or persistent gastrointestinal side effects from Mounjaro that significantly limit your food intake for more than a few days You are taking metformin in addition to Mounjaro, as this combination increases B12 deficiency risk You have a history of pernicious anaemia, gastric surgery, or conditions affecting nutrient absorption You are considering stopping B12 injections whilst taking Mounjaro You experience any unexplained neurological symptoms Urgent medical attention is needed if you develop severe, persistent abdominal pain (which may radiate to the back), persistent vomiting, fever, or yellowing of the skin/eyes, as these could indicate pancreatitis or gallbladder problems Your GP or practice nurse can arrange blood tests to check your B12 levels (serum B12, holotranscobalamin, and if borderline, methylmalonic acid levels may be used where available) and determine the appropriate frequency of B12 injections if deficiency is confirmed

5 Semaglutide Treatment 6 Who is a Candidate for Semaglutide
FDA warning letters are reserved for significant issues and are a matter of public record
Adults over 50
They are not approved for human use by the FDA outside of clinical trials
People Who Prefer Simpler Daily Logistics The pill removes several practical challenges associated with injections: No sharps disposal No injection-site management No injection technique learning curve Less travel complexity Patients Prioritizing Diabetes Management If blood sugar control is the primary goal, oral GLP-1 therapy may provide meaningful glycemic improvement in a format that feels easier to integrate into daily routines